Headquarters
309 PAPA PL, SCHENECTADY, NY 12303-5273, US
SCHENECTADY, NY, US
DIRECTSEQ BIOSCIENCES, INC.
From the company
DirectSeq Biosciences develops RNA sequencing technology, including its DSMX™-Seq platform, which directly sequences RNA molecules without cDNA conversion and identifies modified ribonucleotide bases. The company provides technology services for RNA therapeutics quality assurance, de-novo sequencing of RNA species, and biomarker discovery, built on advanced mass spectrometry and molecular biology.
Products & services offered
Capabilities 7
- Bioinformatics
- de-novo sequencing
- detection of modified bases
- direct RNA sequencing
- LC-MS sequencing data acquisition
- mass spectrometry
View all 7
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.